$PLSE
Pulse Biosciences Inc

2020 Q1 Form 10-K Financial Statement

#000162510120000011 Filed on March 16, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q4 2019 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.600M $7.170M $5.610M
YoY Change 27.27% 87.7% -1.23%
% of Gross Profit
Research & Development $6.181M $6.590M $6.192M
YoY Change 5.8% 29.72% 22.91%
% of Gross Profit
Depreciation & Amortization $100.0K $270.0K $100.0K
YoY Change -38.27% -22.86% -50.0%
% of Gross Profit
Operating Expenses $11.95M $13.93M $11.96M
YoY Change 14.79% 53.76% 9.97%
Operating Profit -$13.79M -$11.75M
YoY Change 54.0% 9.15%
Interest Expense $80.00K $140.0K $220.0K
YoY Change -75.76% 0.0% 83.33%
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change -100.0%
Pretax Income -$11.87M -$13.79M -$11.75M
YoY Change 17.76% 54.08% 9.2%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$11.87M -$13.79M -$11.75M
YoY Change 17.8% 54.0% 9.15%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$569.6K -$663.0K -$565.7K
COMMON SHARES
Basic Shares Outstanding 20.83M 20.79M 20.77M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 Q4 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.89M $25.40M $34.50M
YoY Change -69.91% -57.37% 64.13%
Cash & Equivalents $7.864M $6.899M $9.570M
Short-Term Investments $8.020M $18.50M $24.93M
Other Short-Term Assets $550.0K $1.010M $1.440M
YoY Change 0.0% 29.49% 30.91%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $16.43M $26.40M $35.94M
YoY Change -69.2% -56.26% 62.48%
LONG-TERM ASSETS
Property, Plant & Equipment $2.633M $2.566M $2.428M
YoY Change 28.06% 18.09% 3.81%
Goodwill $2.791M $2.791M $2.791M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $562.0K $494.0K $1.645M
YoY Change 170.19% 389.11% 1528.71%
Total Long-Term Assets $15.41M $15.51M $12.77M
YoY Change 52.57% 50.92% 20.33%
TOTAL ASSETS
Total Short-Term Assets $16.43M $26.40M $35.94M
Total Long-Term Assets $15.41M $15.51M $12.77M
Total Assets $31.84M $41.92M $48.70M
YoY Change -49.82% -40.66% 48.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.214M $1.963M $1.816M
YoY Change 1.17% 54.32% 41.76%
Accrued Expenses $2.071M $2.496M $2.054M
YoY Change 7.86% 75.65% 23.96%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.383M $4.459M $4.047M
YoY Change 8.6% 43.47% 20.88%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $6.690M $6.720M $3.670M
YoY Change 448.36% 460.0% 182.31%
Total Long-Term Liabilities $6.690M $6.720M $3.670M
YoY Change 448.36% 460.0% 182.31%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.383M $4.459M $4.047M
Total Long-Term Liabilities $6.690M $6.720M $3.670M
Total Liabilities $10.07M $11.18M $7.721M
YoY Change 132.2% 159.59% 65.97%
SHAREHOLDERS EQUITY
Retained Earnings -$134.6M -$122.7M -$108.9M
YoY Change 56.84% 62.03% 63.11%
Common Stock $156.3M $153.4M $149.9M
YoY Change 8.0% 58.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $21.77M $30.74M $40.98M
YoY Change
Total Liabilities & Shareholders Equity $31.84M $41.92M $48.70M
YoY Change -49.82% -40.66% 48.82%

Cashflow Statement

Concept 2020 Q1 2019 Q4 2019 Q3
OPERATING ACTIVITIES
Net Income -$11.87M -$13.79M -$11.75M
YoY Change 17.8% 54.0% 9.15%
Depreciation, Depletion And Amortization $100.0K $270.0K $100.0K
YoY Change -38.27% -22.86% -50.0%
Cash From Operating Activities -$9.622M -$9.200M -$7.970M
YoY Change 31.27% 45.8% 16.35%
INVESTING ACTIVITIES
Capital Expenditures $171.0K $40.00K -$540.0K
YoY Change 280.0% -200.0% 671.43%
Acquisitions
YoY Change
Other Investing Activities $10.49M $6.490M $7.090M
YoY Change -129.39% 3.84% 17.0%
Cash From Investing Activities $10.32M $6.530M $6.550M
YoY Change -128.89% 4.98% 9.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $255.0K
YoY Change -6.25%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 264.0K 0.000 200.0K
YoY Change -46.56% -100.0% -50.0%
NET CHANGE
Cash From Operating Activities -9.622M -9.200M -7.970M
Cash From Investing Activities 10.32M 6.530M 6.550M
Cash From Financing Activities 264.0K 0.000 200.0K
Net Change In Cash 965.0K -2.670M -1.220M
YoY Change -102.27% -105.96% 165.22%
FREE CASH FLOW
Cash From Operating Activities -$9.622M -$9.200M -$7.970M
Capital Expenditures $171.0K $40.00K -$540.0K
Free Cash Flow -$9.793M -$9.240M -$7.430M
YoY Change 32.79% 47.37% 9.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei City Area Code
CityAreaCode
510
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
3957 Point Eden Way
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
Hayward
CY2019 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94545
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001625101
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20825469
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2019 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2019 dei Entity File Number
EntityFileNumber
001-34899
CY2019 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q2 dei Entity Public Float
EntityPublicFloat
154277812
CY2019 dei Entity Registrant Name
EntityRegistrantName
Pulse Biosciences, Inc.
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5696597
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 dei Local Phone Number
LocalPhoneNumber
906-4600
CY2019 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2019 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019 dei Trading Symbol
TradingSymbol
PLSE
CY2018Q4 plse Accrued Clinical Trials Current
AccruedClinicalTrialsCurrent
156000
CY2019Q4 plse Accrued Clinical Trials Current
AccruedClinicalTrialsCurrent
262000
CY2019Q4 plse Accrued Property And Equipment
AccruedPropertyAndEquipment
234000
CY2017Q1 plse Area Of Lease
AreaOfLease
15700
CY2019Q4 plse Cash Cash Equivalents Short Term And Long Term Investments
CashCashEquivalentsShortTermAndLongTermInvestments
25400000
CY2017 plse Deferred Rent Landlord Incentive For Tenant Improvements
DeferredRentLandlordIncentiveForTenantImprovements
2119000
CY2019Q4 plse Deferred Tax Asset Lease Liability
DeferredTaxAssetLeaseLiability
1411000
CY2018Q4 plse Deferred Tax Assets Deferred Income And Expense
DeferredTaxAssetsDeferredIncomeAndExpense
111000
CY2019Q4 plse Deferred Tax Assets Deferred Income And Expense
DeferredTaxAssetsDeferredIncomeAndExpense
119000
CY2019Q4 plse Deferred Tax Liability Right Of Use Assets
DeferredTaxLiabilityRightOfUseAssets
1364000
CY2018Q4 plse Fair Value Equity Level12 And3 Transfers Amount
FairValueEquityLevel12And3TransfersAmount
0
CY2019Q4 plse Fair Value Equity Level12 And3 Transfers Amount
FairValueEquityLevel12And3TransfersAmount
0
CY2019Q4 plse Lessee Operating Lease Liability Payments Thereafter
LesseeOperatingLeaseLiabilityPaymentsThereafter
7190000
CY2019 plse Noncash Adjustment Lease Liabilities
NoncashAdjustmentLeaseLiabilities
-76000
CY2019 plse Noncash Adjustment Right Of Use Assets
NoncashAdjustmentRightOfUseAssets
-68000
CY2019 plse Operating Lease Liabilities Arising From Rou Assets Including Impact Of Adopting Asc842
OperatingLeaseLiabilitiesArisingFromRouAssetsIncludingImpactOfAdoptingAsc842
5114000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1297000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11287000
CY2018Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
166000
CY2018Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
167000
CY2018Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
166000
CY2017 plse Proceeds From Exercises Of Stock Options And Warrants
ProceedsFromExercisesOfStockOptionsAndWarrants
539000
CY2018 plse Proceeds From Exercises Of Stock Options And Warrants
ProceedsFromExercisesOfStockOptionsAndWarrants
498000
CY2019 plse Proceeds From Exercises Of Stock Options And Warrants
ProceedsFromExercisesOfStockOptionsAndWarrants
272000
CY2019 plse Proceeds From Rights Offering
ProceedsFromRightsOffering
30000000
CY2018 plse Tax Payments Related To Shares Withheld For Vested Restricted Stock
TaxPaymentsRelatedToSharesWithheldForVestedRestrictedStock
-115000
CY2019 plse Tax Payments Related To Shares Withheld For Vested Restricted Stock
TaxPaymentsRelatedToSharesWithheldForVestedRestrictedStock
-613000
CY2017Q3 plse Tenant Improvement Allowance Capitalized
TenantImprovementAllowanceCapitalized
2100000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1272000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1963000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1421000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2496000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
274000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
51000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
992000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1486000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
142032000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
153401000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10926000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12338000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11287000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10926000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12338000
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
665000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
665000
CY2018Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
166000
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
167000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
666000
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
166000
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9160000
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10764000
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.54
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.64
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
166000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5173000
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5675000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3392778
CY2019Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
167000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3078142
CY2018Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
137000
CY2018Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
118000
CY2018Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
107000
CY2018Q1 us-gaap Interest Income Operating
InterestIncomeOperating
56000
CY2018Q2 us-gaap Interest Income Operating
InterestIncomeOperating
137000
CY2018Q3 us-gaap Interest Income Operating
InterestIncomeOperating
118000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20593000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20825000
CY2018Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2018Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
8481000
CY2019Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
18495000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
21000
CY2018Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
8480000
CY2019Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
18499000
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
8480000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
18499000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20825000
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4139639
CY2017 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2018 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2018Q4 us-gaap Assets
Assets
70640000
CY2019Q4 us-gaap Assets
Assets
41915000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
60362000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
26403000
CY2018Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
59183000
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
24928000
CY2019Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2089000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3386000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51103000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6899000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
47717000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-44204000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20593000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-9163000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-10761000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-8953000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
8724000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
9300000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
10879000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8668000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9163000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10761000
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-8953000
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
48000
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3000
CY2018Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
21000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3960000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5038000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
4409000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25611000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8620000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37495000
CY2018Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8951000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10075000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-46966000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11339000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11760000
CY2019Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13792000
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Concentration </font><font style="display: inline;font-weight:bold;font-style:italic;">of</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;"> Credit Risk</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;text-indent:24.5pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#333333;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents and investments. The Company places its cash equivalents and investments with high credit quality financial institutions and, by policy, limits the amounts invested with any one financial institution or issuer. Deposits held with banks may exceed the amount of insurance provided on such deposits. The Company has not experienced any losses since inception. </font> </p> <p><font size="1"> </font></p> </div> </div>
CY2017 us-gaap Contribution Of Property
ContributionOfProperty
38000
CY2018 us-gaap Contribution Of Property
ContributionOfProperty
33000
CY2019 us-gaap Contribution Of Property
ContributionOfProperty
279000
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
800000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
600000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
600000
CY2018Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
415000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1198000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
23436000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
32167000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
740000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1798000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
15365000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
20755000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
5330000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
665000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5213000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4547000
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-28000
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15503000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2630000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5473000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
22696000
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.51
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
30369000
CY2018Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
740000
CY2019Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
434000
CY2017 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0
CY2018 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0
CY2019 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0
CY2017 us-gaap Depreciation
Depreciation
336000
CY2018 us-gaap Depreciation
Depreciation
645000
CY2019 us-gaap Depreciation
Depreciation
494000
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.73
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.20
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.49
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.26
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.55
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.57
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.66
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.230
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.280
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.180
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.010
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.020
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.020
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.070
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.070
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.050
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Transition Tax On Accumulated Foreign Earnings Percent
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsPercent
18.0
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Transition Tax On Accumulated Foreign Earnings Percent
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsPercent
-2.0
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
938000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1699000
CY2019 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M18D
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
14200000
CY2018 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0
CY2019 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2772000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3438000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1222000
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16881000
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16927000
CY2018Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17656000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
665000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
665000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
665000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
665000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5146000
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5383000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20045000
CY2018Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3814000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4401000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22327000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5606000
CY2019Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7174000
CY2018Q4 us-gaap Goodwill
Goodwill
2791000
CY2019Q4 us-gaap Goodwill
Goodwill
2791000
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
517000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
490000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
646000
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
245000
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
387000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
841000
CY2017 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
101000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
393000
CY2017 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-109000
CY2018 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-397000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
144000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
367000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
226000
CY2017 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
247000
CY2018Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
56000
CY2018 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
418000
CY2019Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
332000
CY2019 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
983000
CY2019Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
290000
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
218000
CY2019Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
143000
CY2017 us-gaap Interest Income Operating
InterestIncomeOperating
247000
CY2018 us-gaap Interest Income Operating
InterestIncomeOperating
446000
CY2018Q4 us-gaap Interest Income Operating
InterestIncomeOperating
135000
CY2019Q1 us-gaap Interest Income Operating
InterestIncomeOperating
332000
CY2019 us-gaap Interest Income Operating
InterestIncomeOperating
983000
CY2019Q2 us-gaap Interest Income Operating
InterestIncomeOperating
290000
CY2019Q3 us-gaap Interest Income Operating
InterestIncomeOperating
218000
CY2019Q4 us-gaap Interest Income Operating
InterestIncomeOperating
143000
CY2017 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-26000
CY2018 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
140000
CY2019 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
521000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10988000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
647000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1094000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1071000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
986000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4269000
CY2017Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2018Q4 us-gaap Liabilities
Liabilities
4306000
CY2019Q4 us-gaap Liabilities
Liabilities
11178000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
70640000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
41915000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3108000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4459000
CY2018Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
0
CY2019Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
0
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35382000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45496000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
82000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22998000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
26117000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10101000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11087000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23896000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34185000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-25567000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-8668000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-37545000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-10078000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-46971000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-11359000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-11746000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-13788000
CY2017 us-gaap Operating Expenses
OperatingExpenses
25814000
CY2018 us-gaap Operating Expenses
OperatingExpenses
37963000
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
9060000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
10410000
CY2019 us-gaap Operating Expenses
OperatingExpenses
47954000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
11649000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
11964000
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
13931000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-25567000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-37545000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10078000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-46971000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11359000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11746000
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-13788000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
6719000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6719000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
406000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5114000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
300000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
200000
CY2019 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y9M29D
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
53000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
250000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
101000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
494000
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-44000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
50000
CY2018Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5000
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
20000
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-14000
CY2019Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4000
CY2018 us-gaap Other Noninterest Expense
OtherNoninterestExpense
28000
CY2018Q4 us-gaap Other Noninterest Expense
OtherNoninterestExpense
28000
CY2017 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
199000
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
115000
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
613000
CY2017 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
43595000
CY2018 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
40297000
CY2019 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
77993000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2551000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
276000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
608000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
779000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1005000
CY2017 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
34843000
CY2018 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
44786000
CY2017 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
23148000
CY2018 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
41815000
CY2019 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
68500000
CY2018 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
24875000
CY2018 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
327000
CY2019 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
423000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3165000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4052000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2173000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2566000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9646000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3175000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17253000
CY2018Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5080000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5842000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24961000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6337000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6192000
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6590000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-75718000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-122689000
CY2017 us-gaap Revenues
Revenues
CY2018 us-gaap Revenues
Revenues
CY2019 us-gaap Revenues
Revenues
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
10926000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
12338000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
11287000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2110219
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3800000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1800000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1000000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
171520
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
99669
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1162616
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2956687
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3749186
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.04
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.18
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
26800000
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
6400000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
8400000
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.75
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
21.61
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
15.66
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.60
CY2019Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
16.33
CY2019 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P6Y6M
CY2018 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y7M6D
CY2019 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y10M24D
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
25298000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
45995000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
66334000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
30737000
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
98928
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
423000
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
34843000
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
CY2018 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
327000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
489000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
498000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
272000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
213000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
512000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
877000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1470000
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
CY2017Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2018Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
262000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
365000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
593000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
37000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities
CY2017 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
CY2018 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
CY2019 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;font-style:italic;">Use of Estimates</font> </p> <p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;text-indent:24.5pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates that affect the amounts reported in the financial statements and accompanying notes to the financial statements. Estimates include, but are not limited to, the valuation of investments, clinical trial accruals, the valuation and recognition of stock-based compensation and useful lives assigned to long-lived assets. Actual amounts could differ from these estimates</font><font style="display: inline;">.</font> </p> <p style="margin:0pt;text-indent:24.5pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p><font size="1"> </font></p> </div> </div>
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14754000
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16842000
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17078000
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20679000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20746000
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20728000
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20774000
CY2019Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20799000

Files In Submission

Name View Source Status
0001625101-20-000011-index-headers.html Edgar Link pending
0001625101-20-000011-index.html Edgar Link pending
0001625101-20-000011.txt Edgar Link pending
0001625101-20-000011-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
plse-20191231.xml Edgar Link completed
plse-20191231.xsd Edgar Link pending
plse-20191231x10k.htm Edgar Link pending
plse-20191231x10kg001.jpg Edgar Link pending
plse-20191231xex10_20.htm Edgar Link pending
plse-20191231xex21_1.htm Edgar Link pending
plse-20191231xex23_1.htm Edgar Link pending
plse-20191231xex23_1g001.jpg Edgar Link pending
plse-20191231xex23_2.htm Edgar Link pending
plse-20191231xex31_1.htm Edgar Link pending
plse-20191231xex31_2.htm Edgar Link pending
plse-20191231xex32_1.htm Edgar Link pending
plse-20191231xex4_6.htm Edgar Link pending
plse-20191231_cal.xml Edgar Link unprocessable
plse-20191231_def.xml Edgar Link unprocessable
plse-20191231_lab.xml Edgar Link unprocessable
plse-20191231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending